ATE1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.817400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.939400E-01
Normal-vs-Stage2
5.679000E-01
Normal-vs-Stage3
2.997200E-01
Normal-vs-Stage4
2.213600E-01
Stage1-vs-Stage2
6.040000E-01
Stage1-vs-Stage3
5.493800E-02
Stage1-vs-Stage4
4.632000E-01
Stage2-vs-Stage3
1.370040E-01
Stage2-vs-Stage4
1.852830E-01
Stage3-vs-Stage4
6.416200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.167200E-01
Normal-vs-AfricanAmerican
2.984200E-01
Normal-vs-Asian
7.810000E-01
Caucasian-vs-AfricanAmerican
7.804400E-02
Caucasian-vs-Asian
8.179000E-01
AfricanAmerican-vs-Asian
2.497800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.611600E-01
Normal-vs-Female
6.167800E-01
Male-vs-Female
8.891600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.782600E-01
Normal-vs-Age(41-60Yrs)
4.292400E-01
Normal-vs-Age(61-80Yrs)
6.608200E-01
Normal-vs-Age(81-100Yrs)
9.477400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.747000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.816200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.386000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.304000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.089190E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.341400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.725600E-01
Normal-vs-Daily Drinker
9.533600E-01
Normal-vs-Weekly Drinker
7.914600E-01
Normal-vs-Occasional Drinker
4.145200E-01
Normal-vs-Social Drinker
6.001800E-01
Non Drinker-vs-Daily Drinker
3.348400E-01
Non Drinker-vs-Weekly Drinker
8.207600E-01
Non Drinker-vs-Occasional Drinker
2.332200E-01
Non Drinker-vs-Social Drinker
7.028800E-01
Daily Drinker-vs-Weekly Drinker
5.757400E-01
Daily Drinker-vs-Occasional Drinker
7.999700E-02
Daily Drinker-vs-Social Drinker
2.846600E-01
Weekly Drinker-vs-Occasional Drinker
2.751200E-01
Weekly Drinker-vs-Social Drinker
6.302400E-01
Occasional Drinker-vs-Social Drinker
5.303600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.485250E-01
Normal-vs-Grade 2
6.146500E-02
Normal-vs-Grade 3
2.661900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.155600E-01
Grade 1-vs-Grade 3
4.814600E-01
Grade 1-vs-Grade 4
1.485250E-01
Grade 2-vs-Grade 3
9.183800E-01
Grade 2-vs-Grade 4
6.146500E-02
Grade 3-vs-Grade 4
2.661900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.460600E-01
Normal-vs-NonDiabetic
6.856200E-01
Diabetic-vs-NonDiabetic
6.580600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.040600E-01
Normal-vs-NoPancreatitis
6.537800E-01
Pancreatitis-vs-NoPancreatitis
7.315800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.275600E-01
Normal-vs-N1
5.587800E-01
N0-vs-N1
6.937600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.504000E-01
Normal-vs-TP53-NonMutant
4.839400E-01
TP53-Mutant-vs-TP53-NonMutant
8.391600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
